Inventor · disambiguated record
Michael Patrick Dillon
Also filed as: DILLON MICHAEL · DILLON MICHAEL PATRICK
57 granted patents·31 pending applications·282 citations·filing 1999–2025
98Inventor score
Top patents by PatentIndex Score
88 records- 0195US7858632B2Diaminopyrimidines as P2X3 and P2X2/3 antagonistsROCHE PALO ALTO LLC·Filed 2005·Granted Dec 28, 2010·28 cites·30 claims
- 0294US10947218B2Aminopyridine derivatives and their use as selective ALK-2 inhibitorsNOVARTIS AG·Filed 2020·Granted Mar 16, 2021·6 cites·13 claims
- 0393US8008313B2Methods of using diaminopyrimidine P2X3 and P2X2/3 receptor modulators for treatment of respiratory and gastrointestinal diseasesROCHE PALO ALTO LLC·Filed 2006·Granted Aug 30, 2011·20 cites·13 claims
- 0493US7531547B2Diaminopyrimidines as P2X3 and P2X2/3 modulatorsROCHE PALO ALTO LLC·Filed 2006·Granted May 12, 2009·38 cites·16 claims
- 0592US2025066309A1Diaminopyrimidines as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2024·Application pending·0 cites
- 0691US12269820B2Piperazine substituted indazole compounds as inhibitors of PARGIDEAYA BIOSCIENCES INC·Filed 2023·Granted Apr 8, 2025·1 cites·12 claims
- 0791US10710980B2Aminopyridine derivatives and their use as selective ALK-2 inhibitorsNOVARTIS AG·Filed 2017·Granted Jul 14, 2020·8 cites·6 claims
- 0890US8846705B2Diaminopyrimidines as P2X3 and P2X2/3 antagonistsBROKA CHRIS ALLEN·Filed 2010·Granted Sep 30, 2014·11 cites·24 claims
- 0990US7799796B2Diaminopyrimidines as P2X3 and P2X2/3 modulatorsROCHE PALO ALTO LLC·Filed 2006·Granted Sep 21, 2010·16 cites·7 claims
- 1089US10709712B2Biaryl amide compounds as kinase inhibitorsNOVARTIS AG·Filed 2019·Granted Jul 14, 2020·3 cites·7 claims
- 1189US2025025462A1Methods of using diaminopyrimidine p2x3 and p2x2/3 receptor modulators for treatment of respiratory and gastrointestinal diseasesROCHE PALO ALTO LLC·Filed 2024·Application pending·0 cites
- 1288US8524725B2Methods of using diaminopyrimidine as P2X3 and P2X⅔ receptor modulators for treatment of respiratory and gastrointestinal diseasesBROKA CHRIS ALLEN·Filed 2011·Granted Sep 3, 2013·9 cites·13 claims
- 1387US10815250B2AhR modulatorsIDEAYA BIOSCIENCES INC·Filed 2019·Granted Oct 27, 2020·3 cites·24 claims
- 1487US7595405B2Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonistsROCHE PALO ALTO LLC·Filed 2007·Granted Sep 29, 2009·7 cites·30 claims
- 1587US2024158356A1Diaminopyrimidines as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2023·Application pending·0 cites
- 1686US7491821B2Inhibitors of P2X3ROCHE PALO ALTO LLC·Filed 2006·Granted Feb 17, 2009·15 cites·15 claims
- 1785US7776872B2Diaminopyrimidines as P2X3 and P2X2/3 modulatorsROCHE PALO ALTO LLC·Filed 2006·Granted Aug 17, 2010·9 cites·10 claims
- 1885US7589090B2Diaminopyrimidines as P2X3 and P2X2/3 modulatorsROCHE PALO ALTO LLC·Filed 2008·Granted Sep 15, 2009·7 cites·16 claims
- 1984US12115163B2Combination therapy comprising a MAT2A inhibitor and a type II PRMT inhibitorIDEAYA BIOSCIENCES INC·Filed 2024·Granted Oct 15, 2024·1 cites·17 claims
- 2084US11407764B2AhR modulatorsIDEAYA BIOSCIENCES INC·Filed 2020·Granted Aug 9, 2022·1 cites·19 claims
- 2184US10245267B2Biaryl amide compounds as kinase inhibitorsNOVARTIS AG·Filed 2017·Granted Apr 2, 2019·3 cites·4 claims
- 2284US9694016B2Biaryl amide compounds as kinase inhibitorsNOVARTIS AG·Filed 2014·Granted Jul 4, 2017·5 cites·8 claims
- 2383US6355641B1Oxazolone derivatives and uses thereofSYNTEX LLC·Filed 2000·Granted Mar 12, 2002·14 cites·30 claims
- 2482US10167279B2Compounds and compositions as RAF kinase inhibitorsNOVARTIS AG·Filed 2015·Granted Jan 1, 2019·3 cites·17 claims
- 2582US8048905B2Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonistsROCHE PALO ALTO LLC·Filed 2008·Granted Nov 1, 2011·4 cites·16 claims
- 2682US2023100975A1Diaminopyrimidines as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2022·Application pending·0 cites
- 2781US8841336B2Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonistsCHEN LI·Filed 2011·Granted Sep 23, 2014·4 cites·17 claims
- 2881US7786110B2Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonistsROCHE PALO ALTO LLC·Filed 2007·Granted Aug 31, 2010·5 cites·16 claims
- 2980US8119644B2Thiadiazole-substituted arylamides as P2X3 and P2X2/3 antagonistsCHEN LI·Filed 2009·Granted Feb 21, 2012·3 cites·37 claims
- 3080US7470684B2Spiropiperidine derivatives as NK3 antagonistsHOFFMANN LA ROCHE·Filed 2007·Granted Dec 30, 2008·6 cites·31 claims
- 3178US8268840B2Pyrimidinyl pyridone inhibitors of kinasesBROOKFIELD FREDERICK·Filed 2009·Granted Sep 18, 2012·8 cites·8 claims
- 3278US8193368B2Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonistsDILLON MICHAEL PATRICK·Filed 2009·Granted Jun 5, 2012·2 cites·34 claims
- 3377US9556127B2Diaminopyrimidines as P2X3 and P2X2/3 antagonistsROCHE PALO ALTO LLC·Filed 2014·Granted Jan 31, 2017·1 cites·9 claims
- 3475US11584755B2Dihydrothieno[3,2-b]pyridine compoundsIDEAYA BIOSCIENCES INC·Filed 2018·Granted Feb 21, 2023·1 cites·18 claims
- 3575US2021009531A1Diaminopyrimidines as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2020·Application pending·0 cites
- 3674US12258354B2AhR modulatorsIDEAYA BIOSCIENCES INC·Filed 2022·Granted Mar 25, 2025·0 cites·14 claims
- 3774US6756395B2Imidazolinyimethyl aralklsulfonamidesROCHE PALO ALTO LLC·Filed 2003·Granted Jun 29, 2004·6 cites·46 claims
- 3874US2021008071A1Methods of using diaminopyrimidine p2x3 and p2x2/3 receptor modulators for treatment of respiratory and gastrointestinal diseasesROCHE PALO ALTO LLC·Filed 2020·Application pending·0 cites
- 3973US2020115347A1Diaminopyrimidines as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2019·Application pending·0 cites
- 4072US2019270713A1Diaminopyrimidines as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2019·Application pending·0 cites
- 4171US8501933B2Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonistsCHEN LI·Filed 2010·Granted Aug 6, 2013·1 cites·32 claims
- 4271US8440708B2Triazole-substituted arylamides as P2X3 and P2X2/3 antagonistsCHEN LI·Filed 2011·Granted May 14, 2013·1 cites·28 claims
- 4370US12466808B2Aminopyridine derivatives and their use as selective ALK-2 inhibitorsNOVARTIS AG·Filed 2021·Granted Nov 11, 2025·0 cites·13 claims
- 4470US10377770B2Tricyclic compounds and compositions as kinase inhibitorsNOVARTIS AG·Filed 2016·Granted Aug 13, 2019·1 cites·30 claims
- 4570US9173861B2Thiadiazole-substituted arylamides as P2X3 and P2X2/3 antagonistsCHEN LI·Filed 2012·Granted Nov 3, 2015·1 cites·20 claims
- 4670US2019016688A1Diaminopyrimidines as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2018·Application pending·0 cites
- 4768US6319920B12-arylethyl-(piperidin-4-ylmethyl)amine derivativesSYNTEX LLC·Filed 1999·Granted Nov 20, 2001·29 cites·35 claims
- 4868US2018141919A1Diaminopyrimidines as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2017·Application pending·0 cites
- 4966US2018311240A1Methods of using diaminopyrimidine p2x3 and p2x2/3 receptor modulators for treatment of respiratory and gastrointestinal diseasesROCHE PALO ALTO LLC·Filed 2018·Application pending·0 cites
- 5065US2017096404A1Diaminopyrimidines as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2016·Application pending·0 cites
Showing the top 50 of 88 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michael Patrick Dillon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →